COVID-19 patient in Legazpi City transferred to hospital | Inquirer News

COVID-19 patient in Legazpi City transferred to hospital

LEGAZPI CITY –– The American citizen who tested positive for coronavirus disease (COVID-19) in this city was admitted to a hospital for quarantine.

Mayor Noel Rosal said the patient was transferred to the Bicol Regional Training and Teaching Hospital (BRTTH) around 9:30 p.m. on Tuesday.

The 52-year-old patient tagged as PH766 arrived in the city on March 8.

ADVERTISEMENT

He had a check-up at the BRTTH on March 16 due to coughing. He was discharged for home quarantine the following day, after a swab test.

FEATURED STORIES

Antonio Ludovice, chief of Albay provincial health office, said that the patient had his second throat swab test last Saturday and now asymptomatic.

His Filipina girlfriend, also a PUI, was also quarantined at the BRTTH, Ludovice said.

They rented an apartment in Barangay Bagumbayan, which was under total lockdown since Friday (March 27) night.

Rosal has also ordered a total lockdown in Barangays Ilawod West and Ilawod for contact tracing and disinfection.

The lockdown order in Ilawod was lifted at 5 p.m. on Tuesday.

The other two COVID-19 patients in the towns of Guinobatan and Bacacay were still on home quarantine.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Legazpi City, Philippine news updates, Quarantine, Regions

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.